Inscription Capital, LLC Astrazeneca PLC Transaction History
Inscription Capital, LLC
- $288 Million
- Q1 2024
A detailed history of Inscription Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Inscription Capital, LLC holds 13,284 shares of AZN stock, worth $1.03 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
13,284
Previous 5,727
131.95%
Holding current value
$1.03 Million
Previous $385,000
133.51%
% of portfolio
0.31%
Previous 0.11%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,248Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.74 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.8 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.32 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.67 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.34 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...